Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Lantern Pharma Inc. (LTRN)

BioLineRx Ltd. and Lantern Pharma Inc. are both Biotechnology companies. BioLineRx Ltd. and Lantern Pharma Inc. are of similar size ($10.2M and $10.0M). Lantern Pharma Inc. has the higher net margin (0.00% vs −502.1%) and the higher return on invested capital (0.00% vs −74.3%). Across the 13 metrics below, Lantern Pharma Inc. leads on 7 and BioLineRx Ltd. on 6.

Valuation

Metric BLRX LTRN Biotechnology median
P/E n/m n/m 8.50
P/S 6.51 n/m 9.71
P/B 0.55 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.93 n/m 9.21
Earnings yield (82.84%) (257.14%) (33.15%)
Free cash flow yield (119.61%) (179.89%) (25.50%)

Profitability

Metric BLRX LTRN Biotechnology median
Gross margin 80.03% 0.00% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (400.91%) (56.36%)
Return on assets (18.21%) (143.36%) (48.04%)
Return on invested capital (74.28%) 0.00% 0.00%

Growth

Metric BLRX LTRN Biotechnology median
Revenue growth (TTM) (91.93%) — 6.02%
EPS growth (last fiscal year) 93.72% 18.65% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX LTRN Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 1.96 4.72
Net debt to EBITDA 1.22 0.56 0.96

Dividend

Metric BLRX LTRN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLRX LTRN Biotechnology median
Market cap 10.21m 9.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack